Glycogen phosphorylase levels in the brain of rats treated with psychotomimetic drugs and with tranquilizers.
D000818:Animals; D001921:Brain / Q000187:drug effects* / Q000201:enzymology*; D002746:Chlorpromazine / Q000494:pharmacology*; D003913:Dextroamphetamine / Q000494:pharmacology*; D006003:Glycogen; D006213:Hallucinogens / Q000494:pharmacology*; D006801:Humans; D006854:Hydrocortisone / Q000494:pharmacology*; D066298:In Vitro Techniques; D007328:Insulin / Q000494:pharmacology*; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology*; D008635:Mescaline / Q000494:pharmacology*; D010770:Phosphotransferases / Q000378:metabolism*; D011618:Psychotic Disorders / Q000209:etiology; D051381:Rats; D013347:Subcellular Fractions / Q000378:metabolism; D014268:Trifluoperazine / Q000494:pharmacology*
D006213:Hallucinogens; D007328:Insulin; D014268:Trifluoperazine; D008238:Lysergic Acid Diethylamide; D006003:Glycogen; D010770:Phosphotransferases; D008635:Mescaline; D003913:Dextroamphetamine; D002746:Chlorpromazine; D006854:Hydrocortisone